Perispinal etanercept: Potential as an Alzheimer therapeutic
2008

Potential of Perispinal Etanercept for Alzheimer's Treatment

Sample size: 15 Commentary Evidence: low

Author Information

Author(s): Griffin W Sue T

Primary Institution: University of Arkansas for Medical Sciences

Hypothesis

Can perispinal etanercept improve cognitive function in Alzheimer's patients?

Conclusion

Perispinal administration of etanercept may lead to sustained cognitive improvements in Alzheimer's patients.

Supporting Evidence

  • The study showed rapid cognitive improvements in patients after treatment.
  • Etanercept is an FDA-approved drug used for other inflammatory conditions.
  • Direct delivery of etanercept to the brain may enhance its effectiveness.

Takeaway

This study suggests that a special injection of a medicine called etanercept can help people with Alzheimer's think better, and it works really fast.

Methodology

A six-month study with 15 probable Alzheimer's patients treated weekly with perispinal etanercept injections.

Potential Biases

Potential bias due to the subjective nature of cognitive improvement assessments.

Limitations

The study is based on a small sample size and lacks extensive clinical trial data.

Participant Demographics

Patients diagnosed with probable Alzheimer's disease.

Digital Object Identifier (DOI)

10.1186/1742-2094-5-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication